EMA begins review of Pfizer COVID jab for young teens as US set to OK it

The US is expected to back the use of the Pfizer/BioNTech vaccine for people aged 12 to 15 within a week. Europe's watchdog launched its review on Monday with a decision expected in June. #BrusselsBureau